New therapeutic target discovered for treatment-resistant melanoma

FHS
June 8, 2024
7:11 am

An international research team led by scientists from the University of Liège (Belgium) has discovered an interesting new therapeutic target for the treatment of melanoma resistant to targeted therapies.

Stryker plans ‘very active’ M&A, ortho robot launches in 2H

By the numbers Q2 revenue: $5.42 billion 8.5% increase year over year Net income: $825 million 11.8% increase year over year Stryker set another record

July 31, 2024

Lexicon cuts about 75 sales jobs to prep for drug launch early next year

Ahead of an FDA decision date later this year, Lexicon Pharmaceuticals is trimming its workforce. The company will lay off roughly half of its sales

August 14, 2024

Girls are starting puberty earlier than ever. For some, that comes with major mental health risks

Zaria was just 9 years old when a nurse practitioner delivered news that rocked her world: The young girl was already showing signs of puberty

March 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.